Are we ready to assess the value of treatment options in oncology?
作者信息
El-Deiry Wafik S
机构信息
a Fox Chase Cancer Center ; Philadelphia , PA USA.
出版信息
Cancer Biol Ther. 2015;16(10):1427-9. doi: 10.1080/15384047.2015.1089121. Epub 2015 Oct 2.
Abstract
摘要
相似文献
1
Are we ready to assess the value of treatment options in oncology?
Cancer Biol Ther. 2015;16(10):1427-9. doi: 10.1080/15384047.2015.1089121. Epub 2015 Oct 2.
2
Personalized Medicine: Genomics Trials in Oncology.
Trans Am Clin Climatol Assoc. 2015;126:133-43.
3
The Future of Cancer Care: Are We Ready For Personalized Value?
J Natl Compr Canc Netw. 2015 Aug;13(8):1049-51. doi: 10.6004/jnccn.2015.0124.
4
Challenging Standard-of-Care Paradigms in the Precision Oncology Era.
Trends Cancer. 2018 Feb;4(2):101-109. doi: 10.1016/j.trecan.2017.12.004. Epub 2018 Jan 12.
5
Moral Duties of Genomics Researchers: Why Personalized Medicine Requires a Collective Approach.
Trends Genet. 2017 Feb;33(2):118-128. doi: 10.1016/j.tig.2016.11.006. Epub 2016 Dec 22.
6
Enabling Precision Oncology Through Precision Diagnostics.
Annu Rev Pathol. 2020 Jan 24;15:97-121. doi: 10.1146/annurev-pathmechdis-012418-012735.
7
[Implementing next-generation sequencing for precision hematology/oncology].
Rinsho Ketsueki. 2018;59(10):1924-1934. doi: 10.11406/rinketsu.59.1924.
8
[Precision Oncology and "Molecular Tumor Boards" - Concepts, Chances and Challenges].
Dtsch Med Wochenschr. 2017 Nov;142(22):1676-1684. doi: 10.1055/s-0042-120717. Epub 2017 Oct 27.
9
Genomics in Hematology and Oncology Practice.
Acta Med Acad. 2019 Apr;48(1):1-5. doi: 10.5644/ama2006-124.237.
10
Next-generation sequencing: from conventional applications to breakthrough genomic analyses and precision oncology.
Expert Rev Med Devices. 2018 Jan;15(1):1-3. doi: 10.1080/17434440.2017.1419059. Epub 2017 Dec 28.
Zotero 插件